• Pharma
  • July 15, 2018
  • 29 views
Patent Challenge To US based Gilead Sciences for Hepatitis-C Medicines

Two oppositions in the Indian patent office are filed by the Patients’ rights advocates in India, challenging patent claims by the US pharmaceutical company Gilead Sciences for its medicines sofosbuvir…